David Oxley

9.3k total citations · 3 hit papers
109 papers, 6.8k citations indexed

About

David Oxley is a scholar working on Molecular Biology, Organic Chemistry and Plant Science. According to data from OpenAlex, David Oxley has authored 109 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 23 papers in Organic Chemistry and 22 papers in Plant Science. Recurrent topics in David Oxley's work include Glycosylation and Glycoproteins Research (23 papers), Carbohydrate Chemistry and Synthesis (23 papers) and Epigenetics and DNA Methylation (19 papers). David Oxley is often cited by papers focused on Glycosylation and Glycoproteins Research (23 papers), Carbohydrate Chemistry and Synthesis (23 papers) and Epigenetics and DNA Methylation (19 papers). David Oxley collaborates with scholars based in United Kingdom, Australia and United States. David Oxley's co-authors include Wolf Reik, Gabriella Ficz, Felix Krueger, Antony Bacic, Miguel R. Branco, Shankar Balasubramanian, Michael J. Booth, Stephen G. Wilkinson, Fátima Santos and Judith Webster and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David Oxley

108 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution

2012 711 citations Michael J. Booth, Miguel R. Branco et al. Science profile →
Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human

2014 696 citations Gabriella Ficz, Felix Krueger et al. profile →
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r

2012 657 citations David Oxley, Wolf Reik et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Oxley United Kingdom	39	5.4k	946	843	735	350	109	6.8k
Ping Liang United States	42	3.7k 0.7×	1.0k 1.1×	440 0.5×	898 1.2×	379 1.1×	151	5.5k
Kangling Zhang United States	34	5.8k 1.1×	686 0.7×	377 0.4×	1.0k 1.4×	326 0.9×	88	6.8k
Frank C. P. Holstege Netherlands	54	8.9k 1.6×	1.1k 1.1×	835 1.0×	722 1.0×	801 2.3×	156	11.1k
Pearlly S. Yan United States	50	6.5k 1.2×	1.3k 1.4×	1.7k 2.1×	296 0.4×	760 2.2×	139	8.6k
Judy L. Meinkoth United States	41	4.6k 0.9×	779 0.8×	423 0.5×	350 0.5×	461 1.3×	82	6.5k
Jun Fu China	38	4.4k 0.8×	1.5k 1.5×	378 0.4×	478 0.7×	332 0.9×	115	5.9k
Jacques Côté Canada	68	14.4k 2.7×	1.3k 1.4×	1.2k 1.4×	1.5k 2.0×	654 1.9×	163	16.3k
Simone Sidoli United States	44	4.8k 0.9×	395 0.4×	578 0.7×	318 0.4×	437 1.2×	190	6.1k
Jessica K. Tyler United States	43	6.7k 1.2×	557 0.6×	405 0.5×	901 1.2×	329 0.9×	101	7.7k
Alan F. Scott United States	33	5.0k 0.9×	2.5k 2.7×	454 0.5×	1.8k 2.5×	350 1.0×	74	7.5k

Countries citing papers authored by David Oxley

Since Specialization

Citations

This map shows the geographic impact of David Oxley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Oxley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Oxley more than expected).

Fields of papers citing papers by David Oxley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Oxley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Oxley. The network helps show where David Oxley may publish in the future.

Co-authorship network of co-authors of David Oxley

This figure shows the co-authorship network connecting the top 25 collaborators of David Oxley. A scholar is included among the top collaborators of David Oxley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Oxley. David Oxley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eckersley-Maslin, Mélanie, et al.. (2024). Exploring the Stability of Genomic Imprinting and X-Chromosome Inactivation in the Aged Brain. 2(1). 20240030–20240030. 3 indexed citations

Bertran, M. Teresa, Robert Walmsley, Iker Valle Aramburu, et al.. (2024). A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation. Nature Communications. 15(1). 9746–9746. 5 indexed citations

Baker, Martin J., Anna‐Karin Johnsson, Melanie Stammers, et al.. (2023). The Rac-GEF Tiam1 controls integrin-dependent neutrophil responses. Frontiers in Immunology. 14. 1223653–1223653. 6 indexed citations

Eckersley-Maslin, Mélanie, Felix Krueger, Annalisa Mupo, et al.. (2022). Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation. Nature Communications. 13(1). 5432–5432. 11 indexed citations

Lochhead, Pamela A., Julie A. Tucker, Natalie J. Tatum, et al.. (2020). Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors. Nature Communications. 11(1). 1383–1383. 33 indexed citations

Hore, Timothy A., Ferdinand von Meyenn, Mirunalini Ravichandran, et al.. (2016). Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms. Proceedings of the National Academy of Sciences. 113(43). 12202–12207. 128 indexed citations

Clark, Jonathan, Robert R. Kay, Anna Kielkowska, et al.. (2014). Dictyostelium uses ether‐linked inositol phospholipids for intracellular signalling. The EMBO Journal. 33(19). 2188–2200. 47 indexed citations

Oxley, David, et al.. (2014). The Nuclear Exosome Is Active and Important during Budding Yeast Meiosis. PLoS ONE. 9(9). e107648–e107648. 10 indexed citations

Ficz, Gabriella, Timothy A. Hore, Fátima Santos, et al.. (2013). FGF signalling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Clinical Epigenetics. 5(S1). 154 indexed citations

10.

Ficz, Gabriella, Timothy A. Hore, Fátima Santos, et al.. (2013). FGF Signaling Inhibition in ESCs Drives Rapid Genome-wide Demethylation to the Epigenetic Ground State of Pluripotency. Cell stem cell. 13(3). 351–359. 301 indexed citations

11.

Oda, Masaaki, David Oxley, Wendy Dean, & Wolf Reik. (2013). Regulation of Lineage Specific DNA Hypomethylation in Mouse Trophectoderm. PLoS ONE. 8(6). e68846–e68846. 37 indexed citations

12.

Booth, Michael J., Miguel R. Branco, Gabriella Ficz, et al.. (2012). Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution. Science. 336(6083). 934–937. 711 indexed citations breakdown →

13.

Royce, Simon G., et al.. (2010). A Novel Foregut Mucin Characterized by a Murine Monoclonal Autoantibody. Hybridoma. 29(2). 84–101.

14.

Herbert, Ben, Femia G. Hopwood, David Oxley, et al.. (2003). β‐elimination: An unexpected artefact in proteome analysis. PROTEOMICS. 3(6). 826–831. 38 indexed citations

15.

Gaber, Osama, et al.. (1991). Changes in Gastric Emptying in Recipients of Successful Combined Pancreas-Kidney Transplants. Digestive Diseases. 9(6). 437–443. 51 indexed citations

16.

Oxley, David & Stephen G. Wilkinson. (1991). Structure of an acidic glycan present in the lipopolysaccharide extract from the reference strain for Serratia marcescens serogroup O18. Carbohydrate Research. 215(2). 293–301. 5 indexed citations

17.

Oxley, David & Stephen G. Wilkinson. (1991). Structure of a glucorhamnan from the lipopolysaccharide of Serratia marcescens strain S1254. Carbohydrate Research. 209. 319–322. 6 indexed citations

18.

Oxley, David & Stephen G. Wilkinson. (1990). A common structure for neutral polymers isolated from the lipopolysaccharides of reference strains for Serratia marcescens serogroups O17 and O19. Carbohydrate Research. 198(1). 168–172. 5 indexed citations

19.

Oxley, David & Stephen G. Wilkinson. (1989). Structural studies of an acidic galactoglucomannan from the O15 reference strain (C.D.C. 4523-60) of Serratia marcescens. Carbohydrate Research. 186(2). 295–300. 4 indexed citations

20.

Oxley, David & Stephen G. Wilkinson. (1989). Structural studies of an acidic galactoglucomannan from the O3 reference strain (C.D.C. 863-57) of Serratia marcescens. Carbohydrate Research. 187(2). 295–301. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact